Wednesday, November 07, 2018 1:22:45 AM
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
DuVal, Fred Price
4 - Director of Issuer
Options Incentive Stock
50 - Grant of options
+500,000 vol
600,000
Filing date: 2018-11-06
Transaction: 2018-11-05
$MIN
Excelsior Mining Corp.
Paine, Sheila Margaret
5 - Senior Officer of Issuer
Options Incentive Stock
51 - Exercise of options
-40,000 vol
30,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Renwick, Robin
4 - Director of Issuer
Options Incentive Stock
50 - Grant of options
+600,000 vol
1,100,000
Filing date: 2018-11-06
Transaction: 2018-11-05
$MIN
Excelsior Mining Corp.
Paine, Sheila Margaret
5 - Senior Officer of Issuer
Common Shares
51 - Exercise of options
$8,326.50
+27,755 vol
$0.30 each
27,755
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Kinley, Colin Brent
4 - Director of Issuer
Options Incentive Stock
50 - Grant of options
+580,000 vol
1,230,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Axcell, Stephen
4 - Director of Issuer
Options Incentive Stock
50 - Grant of options
+600,000 vol
600,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Kolbe, Jim
4 - Director of Issuer
Options Incentive Stock
50 - Grant of options
+600,000 vol
1,250,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Dahl, Barry
5 - Senior Officer of Issuer
Options Incentive Stock
50 - Grant of options
+200,000 vol
200,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Haworth, Michael John
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Options Incentive Stock
50 - Grant of options
+600,000 vol
600,000
Filing date: 2018-11-06
Transaction: 2018-11-02
$MIN
Excelsior Mining Corp.
Morabito, Mark Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Options Incentive Stock
50 - Grant of options
+850,000 vol
850,000
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM